Am J Transplant, Volume 20, Suppl 3 Archives - Page 140 of 223 - ATC Abstracts

2020 American Transplant Congress
Safety and Efficacy of Endoscopic Transpapillary Gallbladder Stenting for Symptomatic Gallbladder Disease in Cirrhosis: A Systematic Review and Meta-Analysis
K. F. Haq¹, U. Iqbal², M. Khan³, F. Kamal⁴, S. Solanki⁵, R. Chakinala⁵, M. Siddiqui¹, M. Abu Ghanimeh¹, O. Sadiq¹, A. Watson¹, T. Zuchelli¹, R. Salgia¹
¹Gastroenterology & Hepatology, Henry Ford Hospital, Detroit, MI, ²Medicine, Geisinger Medical Center, Danville, PA, ³Gastroenterology & Hepatology, University of Alabama, Birmingham, AL, ⁴Gastroenterology & Hepatology, University of Tennessee, Knoxville, TN, ⁵Medicine, Guthrie Hospital, Sayre, PA
*Purpose: Endoscopic transpapillary gallbladder (cystic duct) stenting has been shown to be an effective treatment option for symptomatic gallbladder disease in patients with cirrhosis. However,…
2020 American Transplant Congress
Long Term Outcomes Following Uncontrolled and Controlled Donation after Cardiac Death Liver Transplantation in the United States
R. A. Choudhury¹, D. Yoeli¹, H. Yaffe¹, H. B. Moore¹, G. Hoeltzel², A. Schulick¹, K. D. Conzen¹, J. J. Pomposelli¹, E. A. Pomfret¹, T. L. Nydam¹
¹Department of Surgery- Division of Transplantation Surgery, University of Colorado Hospital, Aurora, CO, ²Thomas Jefferson University Hospital, Philadelphia, PA
*Purpose: Poor short-term outcomes following uncontrolled donation after cardiac death (uDCD) liver transplantation has led to near non-utilization of such donor allografts in the modern…
2020 American Transplant Congress
Living Donor Liver Transplantation for Hepatocellular Carcinoma Beyond UCSF Criteria: Tumor Biology Not the Tumor Number Decide the Long Term Outcome- A Single Center Retrospective Analysis of Using Extended Criteria
A. Thorat, L. Jeng, S. Hsu, H. Yang, P. Li, T. Chen, K. Poon
Organ Transplantation Center, China Medical University Hospital, Taichung, Taiwan
*Purpose: HCC is the fifth most common cancer and the third most frequent cause of cancer deaths worldwide. After its introduction for LT in HCC…
2020 American Transplant Congress
Center Performance for Liver Retransplantation Candidates is More Heterogeneous Than for Initial Liver Transplantation Recipients
T. Bittermann, P. L. Abt, D. E. Schaubel
University of Pennsylvania, Philadelphia, PA
*Purpose: This study evaluated center performance for wait-list outcomes for adult candidates awaiting liver retransplantation (reLT), and its association with initial liver transplant (iLT) center…
2020 American Transplant Congress
NASH is the Leading Indication for Liver Transplantation in Elderly Patients
J. A. Steggerda¹, J. Yang², V. Sundaaram², N. Alkouri³, W. Ayoub², I. K. Kim¹, M. Noureddin²
¹Surgery, Cedars-Sinai Medical Center, Los Angeles, Los Angeles, CA, ²Hepatology, Cedars-Sinai Medical Center, Los Angeles, Los Angeles, CA, ³Gastroenterology, University of Texas Health- San Antonio, San Antonio, TX
*Purpose: Non-alcoholic steatohepatitis (NASH) is an increasingly prevalent cause of end-stage liver disease (ESLD) and indication for liver transplantation (LT) in the United States and…
2020 American Transplant Congress
Twice Weekly Valganciclovir for Cytomegalovirus Infection Prophylaxis in Kidney Transplant Recipients with Delayed Graft Function on Hemodialysis
S. A. Mehta¹, A. Katz², R. Dieter², P. Jen², J. Siegfried², J. Papadopoulos², T. Lewis²
¹Infectious Diseases, NYU Langone Health, New York, NY, ²Pharmacy, NYU Langone Health, New York, NY
*Purpose: The incidence of cytomegalovirus (CMV) remains high in the first year following kidney transplantation. Valganciclovir (VGC) is commonly prescribed in the early post-operative period…
2020 American Transplant Congress
Does Transplantation of Hepatitis C Infected Kidneys Into Uninfected Recipients Cause Hepatitis C-Associated Kidney Injury?
R. H. Naik, S. Shawar, R. C. Forbes, H. Schaefer, D. Shaffer, M. Rossi, V. Imperio, B. P. Concepcion, M. Kapp
Vanderbilt University Medical Center, Nashville, TN
*Purpose: With increasing utilization of Hepatitis C infected (HCV+) kidneys for transplantation into uninfected (HCV-) recipients, there is concern for the development of HCV-associated kidney…
2020 American Transplant Congress
Preoperative Antibody Titer Against BK Polyomavirus May Predict BK Polyomavirus-Associated Nephropathy after Kidney Transplantation
M. Saito, S. Satoh, K. Numakura, R. Sagehashi, R. Yamamoto, A. Koizumi, T. Nara, S. Narita, T. Habuchi
Urology, Akita University Hospital, Akita, Japan
*Purpose: BK polyomavirus (BKPyV) is a causative agent of BKPyV-associated nephropathy (BKPyV-AN) and hemorrhagic cystitis, which occurs subsequent to BKPyV reactivation. Intravenous immunoglobulin is presumed…
2020 American Transplant Congress
Pharmacist Initiated Hepatitis B Vaccinations in Liver Transplant Recipients
A. Reid¹, S. Todd¹, M. Morrison², A. Adams¹
¹Emory University Hospital, Atlanta, GA, ²Vanderbilt University Medical Center, Nashville, TN
*Purpose: The risk of developing hepatitis B after liver transplantation remains high in nonimmune patients receiving an allograft from a hepatitis B core antibody positive…
2020 American Transplant Congress
Cardiovascular Improvement after Pancreatic Transplantation
S. Y. Suen¹, T. Sparkes¹, R. Kalil², B. Ravichandran¹
¹Pharmacy, University of Maryland Medical Center, Baltimore, MD, ²Nephrology, University of Maryland Medical Center, Baltimore, MD
*Purpose: Cardiovascular disease is a common cause of mortality in patients with uncontrolled diabetes. The purpose of this study is to assess whether patients receiving…